1. Home
  2. MXCT vs SVCC Comparison

MXCT vs SVCC Comparison

Compare MXCT & SVCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • SVCC
  • Stock Information
  • Founded
  • MXCT 1999
  • SVCC 2024
  • Country
  • MXCT United States
  • SVCC United States
  • Employees
  • MXCT N/A
  • SVCC N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SVCC
  • Sector
  • MXCT Health Care
  • SVCC
  • Exchange
  • MXCT Nasdaq
  • SVCC Nasdaq
  • Market Cap
  • MXCT 239.2M
  • SVCC 220.9M
  • IPO Year
  • MXCT 2021
  • SVCC 2025
  • Fundamental
  • Price
  • MXCT $2.24
  • SVCC $10.22
  • Analyst Decision
  • MXCT Strong Buy
  • SVCC
  • Analyst Count
  • MXCT 1
  • SVCC 0
  • Target Price
  • MXCT $9.00
  • SVCC N/A
  • AVG Volume (30 Days)
  • MXCT 717.0K
  • SVCC 27.9K
  • Earning Date
  • MXCT 08-06-2025
  • SVCC 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • SVCC N/A
  • EPS Growth
  • MXCT N/A
  • SVCC N/A
  • EPS
  • MXCT N/A
  • SVCC N/A
  • Revenue
  • MXCT $37,675,000.00
  • SVCC N/A
  • Revenue This Year
  • MXCT $8.82
  • SVCC N/A
  • Revenue Next Year
  • MXCT $21.12
  • SVCC N/A
  • P/E Ratio
  • MXCT N/A
  • SVCC N/A
  • Revenue Growth
  • MXCT N/A
  • SVCC N/A
  • 52 Week Low
  • MXCT $2.00
  • SVCC $9.95
  • 52 Week High
  • MXCT $5.20
  • SVCC $10.31
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 48.76
  • SVCC N/A
  • Support Level
  • MXCT $2.16
  • SVCC N/A
  • Resistance Level
  • MXCT $2.29
  • SVCC N/A
  • Average True Range (ATR)
  • MXCT 0.12
  • SVCC 0.00
  • MACD
  • MXCT 0.01
  • SVCC 0.00
  • Stochastic Oscillator
  • MXCT 71.20
  • SVCC 0.00

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About SVCC Stellar V Capital Corp. Class A Ordinary Shares

Stellar V Capital Corp is a blank check company.

Share on Social Networks: